Cover Image
市場調查報告書

骨惡性纖維組織細胞瘤:全球臨床實驗檢討

Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 299724
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
Back to Top
骨惡性纖維組織細胞瘤:全球臨床實驗檢討 Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月31日 內容資訊: 英文 131 Pages
簡介

本報告提供骨惡性纖維組織細胞瘤相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及G7各國的臨床實驗狀況,各地區、各階段、Phase別的進行狀況,彙整有潛力的贊助商,在各研究機關的研究的進展,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • 骨惡性纖維組織細胞瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量

在G7各國臨床實驗數量:佔腫瘤整體比率

在G7各國臨床實驗數量:各階段(Phase別)

在G7各國臨床實驗數量:各進展狀況

各階段(Phase別)臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商的不同種類的臨床實驗數量

有潛力的藥劑

臨床實驗簡介

  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Children's Oncology Group
    • St. Jude Children's Research Hospital
    • European Paediatric Soft Tissue Sarcoma Study Group
    • University of Miami Sylvester Comprehensive Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Societe Internationale d'Oncologie Pediatrique
    • National Center for Research Resources
    • The University of Texas M. D. Anderson Cancer Center

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2071CTIDB

GlobalData's clinical trial report, "Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014" provides data on the Malignant Fibrous Histiocytoma Of Bone clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Fibrous Histiocytoma Of Bone. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Fibrous Histiocytoma Of Bone. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Malignant Fibrous Histiocytoma Of Bone
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Malignant Fibrous Histiocytoma Of Bone to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Malignant Fibrous Histiocytoma Of Bone
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • St. Jude Children's Research Hospital
      • Clinical Trial Overview of St. Jude Children's Research Hospital
      • European Paediatric Soft Tissue Sarcoma Study Group
      • Clinical Trial Overview of European Paediatric Soft Tissue Sarcoma Study Group
      • University of Miami Sylvester Comprehensive Cancer Center
      • Clinical Trial Overview of University of Miami Sylvester Comprehensive Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Societe Internationale d'Oncologie Pediatrique
      • Clinical Trial Overview of Societe Internationale d'Oncologie Pediatrique
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Region, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Malignant Fibrous Histiocytoma Of Bone to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by European Paediatric Soft Tissue Sarcoma Study Group, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami Sylvester Comprehensive Cancer Center, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by Societe Internationale d'Oncologie Pediatrique, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*

List of Figures

  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Malignant Fibrous Histiocytoma Of Bone to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Malignant Fibrous Histiocytoma Of Bone Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top